Summit Therapeutics Earnings
NASDAQ: SMMTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Mon, Oct 19, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.28
Summit Therapeutics earnings summary
Summit Therapeutics is scheduled to report Sep/2026 earnings on Oct 19, 2026, with analysts expecting EPS of $-0.28. In its most recent report on Jul 23, 2026 (Q2 2026), SMMT posted EPS of $-0.28. Across the last 16 reports, SMMT shares moved an average of 6.7% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
SMMT earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Jul 23, 2026 | — | $-0.28 | — | -4.7% |
| Apr 30, 2026 | — | $-0.24 | — | +12.2% |
| Feb 23, 2026 | — | $-0.28 | — | -8.9% |
| Oct 20, 2025 | — | $-0.31 | — | -1.9% |
| Aug 11, 2025 | — | $-0.76 | — | -1.8% |
| May 1, 2025 | — | $-0.09 | — | -14.1% |
| Feb 24, 2025 | — | $-0.08 | — | -14.1% |
| Oct 30, 2024 | — | $-0.08 | — | +12.7% |
| Aug 6, 2024 | — | $-0.09 | — | +7.6% |
| May 1, 2024 | — | $-0.06 | — | +5.9% |
| Feb 20, 2024 | — | $0.49 | — | +0.2% |
| Nov 7, 2023 | — | $-0.03 | — | +1.3% |
| Aug 9, 2023 | — | $-0.02 | — | +2.3% |
| May 11, 2023 | — | $-1.43 | — | -2.3% |
| Mar 9, 2023 | — | $-0.04 | — | +12.1% |
| Nov 9, 2022 | — | $-0.10 | — | -5.0% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.